Leonard S. Schleifer, Bd. Co-Chair, President & CEO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 216,010 shares at $988.76 ($211.2M) on 2024-05-15, disclosed to the SEC on 2024-05-15.
Scheduled sale ($211.2M) by Bd. Co-Chair, President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $976.79 | 144,433 | $141.1M | 66.8% |
| 2 | $979.16 | 22,698 | $22.2M | 10.5% |
| 3 | $979.16 | 22,698 | $22.2M | 10.5% |
| 4 | $980.10 | 2,302 | $2.3M | 1.1% |
| 5 | $980.10 | 2,302 | $2.3M | 1.1% |
| 6 | $979.05 | 7,864 |
| $7.7M |
| 3.6% |
| 7 | $979.05 | 7,864 | $7.7M | 3.6% |
| 8 | $980.64 | 295 | $289K | 0.1% |
| 9 | $980.64 | 295 | $289K | 0.1% |
| 10 | $981.50 | 1,081 | $1.1M | 0.5% |
| 11 | $981.50 | 1,081 | $1.1M | 0.5% |
| 12 | $982.66 | 235 | $231K | 0.1% |
| 13 | $982.66 | 235 | $231K | 0.1% |
| 14 | $983.91 | 250 | $246K | 0.1% |
| 15 | $983.91 | 250 | $246K | 0.1% |
| 16 | $984.00 | 305 | $300K | 0.1% |
| 17 | $985.72 | 281 | $277K | 0.1% |
| 18 | $985.72 | 281 | $277K | 0.1% |
| 19 | $986.57 | 103 | $102K | 0.0% |
| 20 | $986.57 | 103 | $102K | 0.0% |
| 21 | $987.46 | 228 | $225K | 0.1% |
| 22 | $987.46 | 228 | $225K | 0.1% |
| 23 | $988.76 | 299 | $296K | 0.1% |
| 24 | $988.76 | 299 | $296K | 0.1% |
| Total | $977.71 avg | 216,010 | $211.2M | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |
| REGN | SELL | 2022-04-04 | $4.1M | — | Filing → |